#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Kent Grindstaff Email
SVP Research . CohBar
Menlo Park, CA
LocationPrimary Email
How to contact Kent Grindstaff
Join and see Kent's contact info for free!Current Roles
Employees:
9Revenue:
$1.4MAbout
CohBar (NASDAQ: CWBR) is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. Mitochondria based therapeutics originate from the discovery by CohBar’s founders of a novel group of naturally occurring mitochondrial-derived peptides within the mitochondrial genome that regulate metabolism and cell death, and whose biological activity declines with age. To date, the company has discovered more than 100 mitochondrial derived peptides and generated over 1,000 analogs. CohBar’s efforts focus on the development of these peptides into therapeutics that offer the potential to address a broad range of diseases, including nonalcoholic steatohepatitis (NASH), obesity, fibrotic diseases, cancer, type 2 diabetes, and cardiovascular and neurodegenerative diseases. The company’s lead compound, CB4211, is in the Phase 1b stage of a Phase 1a/1b clinical trial for NASH and obesity. In addition, CohBar has four preclinical programs, two in cancer, one in fibrotic diseases and one in type 2 diabetes. For additional company information, please visit www.cohbar.com.CohBar Address
1455 Adams DriveMenlo Park, CA
United States